William Douglas Figg is an American scientist (pharmacologist).[1] He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.[2][3] He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section.[4] Figg is also the Co-chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.[5][6]
Figg has more than 850 peer-reviewed articles, and his work has been mentioned over 60,000 times in the scholarly literature. He has an H-index of 130 and an i10-index of 658, both indicators of scientific influence. He has published/edited six books.[7]
Education
editFigg grew up in Beaver Dam, Kentucky, and graduated from Ohio County High School, in Hartford, Kentucky (1981). He earned a BS in pharmacy from Samford University, and a doctoral degree in pharmacy from Auburn University.[8][9] He completed an internship at the UAB Hospital (1990) and a fellowship in drug development at the UNC Eshelman School of Pharmacy (1992). He is a recipient of honorary degrees from Georgetown College and the Philadelphia College of Osteopathic Medicine.[10]
Research and career
editFigg is an expert in molecular pharmacology and clinical pharmacology, as well as the application of pharmacological concepts to the creation of anticancer drugs and biomarkers.[11][12] Figg is presently an adjunct professor of medicine at Columbia University, Vagelos College of Physicians and Surgeons, Department of Medicine, Division of Oncology, New York, NY, a clinical professor of pharmacy at Virginia Commonwealth University, School of Pharmacy, Department of Pharmacotherapy and Outcomes Science, Richmond, VA, and adjunct professor of surgery at Uniformed Services University, School of Medicine, Department of Surgery, Bethesda, MD.[13] Additionally, Figg is a retired captain from the Commissioned Corps of the United States Public Health Service.[14]
Awards and honors
editFigg has received awards including the Leon Goldberg Award from the American Society of Clinical Pharmacology and Therapeutics,[15] the Allen J. Brands Award from United States Public Health Service, the Russell R. Miller Award and the Therapeutics Frontier Award from American College of Clinical Pharmacy,[16] the Andrew Craigie Award from Association of Military Surgeons of the United States, the Philip C. and Ethel F. Ashby Lecture from the University of Oklahoma, the Sustained Contribution to the Scientific Literature Award from the American Society of Health-System Pharmacists Foundation, the Tyler Prize for Stimulation of Research from the American Pharmacists Association, the Charles Hatfield Lecture at Georgetown College, and the Albert Ebert Memorial Lecture University of Illinois.[17] He has received the NIH's Clinical Center Director Award (2007, 2012, 2015), NCI's Outstanding Mentor Award (2008), and NIH's Director Merit Award (2011). Figg is a fellow of the American Colleges of Clinical Pharmacy and Clinical Pharmacology.
References
edit- ^ "ccr.cancer.gov".
- ^ "Speaker - Cell Symposia: Overcoming Therapy Resistance in Cancer". www.cell-symposia.com. Retrieved 2023-03-02.
- ^ "William Douglas Figg | Longdom Publishing SL". www.longdom.org. Retrieved 2023-03-02.
- ^ Biotechnology, Solvo. "Speakers of Meet the Experts Transporter Conference series - Solvo Biotechnology". www.solvobiotech.com. Retrieved 2023-03-02.
- ^ "HJF Scientist Receives Young Investigator Award | HJF". www.hjf.org. Retrieved 2023-03-02.
- ^ "meetings.asco.org".
- ^ "William Douglas Figg, Sr". scholar.google.com. Retrieved 2023-03-02.
- ^ "Use Degree to Make a Difference, Figg Urges Pharmacy Grads". Samford University. Retrieved 2023-03-02.
- ^ "Loop | William Douglas Figg". loop.frontiersin.org. Retrieved 2023-03-02.
- ^ "William Douglas Figg, Sr., Pharm.D. | Principal Investigators | NIH Intramural Research Program". irp.nih.gov. Retrieved 2023-03-02.
- ^ "Research News". ssl.uh.edu. Retrieved 2023-03-02.
- ^ Schmidt, Keith T.; Figg, William D. (November 2016). "The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies". Translational Cancer Research. 5 (Suppl 6): S1107–S1110. doi:10.21037/tcr.2016.11.04. ISSN 2219-6803. PMC 6320229. PMID 30613476.
- ^ "Scholars". clarivatevivo.com. Retrieved 2023-03-02.
- ^ Biotechnology, Solvo. "Speakers of Meet the Experts Transporter Conference series - Solvo Biotechnology". www.solvobiotech.com. Retrieved 2023-03-02.
- ^ "William Douglas Figg | Longdom Publishing SL". www.longdom.org. Retrieved 2023-03-02.
- ^ "onlinelibrary.wiley.com".
- ^ Figg, William D. (January 2006). "The 2005 Leon I. Goldberg Young Investigator Award Lecture: Development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer". Clinical Pharmacology and Therapeutics. 79 (1): 1–8. doi:10.1016/j.clpt.2005.09.006. ISSN 0009-9236. PMID 16413236. S2CID 37397344.